H-E-B's Martin Otto wins leadership award

The editors of <i>Chain Drug Review</i> have bestowed the publication's Industry Leadership Award to H-E-B executive Martin Otto. During his yearlong term as NACDS chairman, Otto encouraged his colleagues to view community pharmacy in the context of health care as a whole.

The editors of Chain Drug Review have bestowed the publication's Industry Leadership Award to H-E-B executive Martin Otto. During his yearlong term as NACDS chairman, Otto encouraged his colleagues to view community pharmacy in the context of health care as a whole. Otto was H-E-B's chief merchant and CFO at the time he was NACDS chairman, and he has since been promoted to COO at the food/drug combination store chain. As NACDS chairman, Otto was dedicated to closely examining pharmacy business and its relation to American society. Data assembled by Otto revealed that the U.S. spends significantly more on health care than any other nation. A recent CMS analysis found that U.S. health care spending reached at $3.3 trillion in 2016, or 17.9% of GDP. Otto points out the share of GDP here contrasts with levels of 8%–12% in other industrialized countries. To achieve the results sought by NACDS, it will be necessary to focus on coalition building with other health care groups and effective advocacy for further changes in public policy. Otto, who remains an active member of the NACDS board, will help advance the cause when he participates in the World Health Care Congress, which is scheduled for April 29 to May 2 in Washington, D.C.